Novo Nordisk, established in 1923 and based in Denmark, stands as a prominent global healthcare enterprise. Our mission revolves around instigating change to conquer diabetes and other significant chronic ailments like obesity, rare blood disorders, and endocrine disorders. This commitment propels us to lead in scientific innovations, enhance the availability of our medications, and actively contribute to preventing and ultimately eradicating diseases. With a workforce of approximately 54,400 individuals spanning 80 countries, Novo Nordisk markets its products in roughly 170 countries. For further details, please visit novonordisk.com.
